The Digital PCR-dPCR Market size was valued at US$ 419.25 Million in 2022 and is projected to reach US$ 2196.40 Million by 2030, with a growing CAGR of 23% during the forecast period 2023-2030.

Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/1038

The Digital PCR (dPCR) market is witnessing significant growth due to the increasing demand for precise and sensitive molecular diagnostics. dPCR is a revolutionary technology that enables the quantification and detection of nucleic acids with unparalleled accuracy and precision.

One of the key factors driving the growth of the dPCR market is its ability to detect rare genetic mutations or variations in a sample. This makes it an invaluable tool in various fields such as cancer research, infectious disease diagnostics, prenatal testing, and genetic testing. The high sensitivity of dPCR allows researchers and clinicians to identify and monitor low-frequency genetic alterations that may have significant implications for disease diagnosis, prognosis, and treatment.

Moreover, dPCR offers several advantages over traditional PCR methods. It eliminates the need for standard curves or reference materials by directly counting individual DNA molecules in a sample. This not only improves accuracy but also reduces the chances of false-positive or false-negative results.

KEY MARKET SEGMENTS

By Technology

  • Droplet Digital PCR
  • Chip Based Digital PCR
  • Beaming Digital PCR

By  Product Type

  • Digital PCR Systems
  • Consumables And Reagents
  • Software And Services

By Application

  • Clinical Diagnostics
  • Forensic And Others
  • Research

By End-Use

  • Pharmaceuticals And Biotechnology Industries
  • Clinical Diagnostic Laboratories
  • Universities And Other Organizations

Major Players Listed in the Report are as Follows:

Thermo Fisher Scientific, Bio-Rad Laboratories Inc., Hoffmann-La Roche, Ltd., Abbott Laboratories, Agilent Technologies, Analytik Jena AG, Becton Dikinson and Company, bioMérieux SA, Danaher Corporation, Eppendorf, Fluidigm Corporation, Merck KGaA, QIAGEN N.V., Takara Bio, Meridian Bioscience, Promega Corporation, Enzo Life Sciences, Inc., Bioneer, ELITech Group, Quidel Corporation, and Others.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

[email protected],

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)